"IGENOMEDX, INC. was formed February 6, 2015 as a Texas Corporation. The founders are two PH.D.s presently at the University of Texas Health Science Center in San Antonio.

iGenomeDx, Inc. will offer five products initially in the line of pharmacogenomics targeted towards physicians practicing in the field of neurology, psychiatry, cardiology and oncology. In addition, iGenomeDx will also offer molecular diagnostics for infectious diseases.

The goal of pharmacogenomics is to help doctors select the drugs and dosages best suited or tailored for each person through genetic testing to ensure maximum efficacy with minimal adverse effects.

This type of lab testing is in great demand for the central US, and it makes San Antonio a prime location, without taking into consideration the other possible additional markets like Houston, Dallas, Fort Worth, Austin, the Rio Grande Valley, and all the other big cities in Texas including the central United States region. "